NASA's SpaceX CRS-35 resupply mission is set to launch from Cape Canaveral Space Force Station in Florida, carrying experiments on human and plant health and drug-resistant organisms to the International Space Station, the agency said in an Oct. 12, 2026, article. Four investigations come from NASA's Biological and Physical Sciences division.

One precision health study sends small, lab-grown models of the human brain to the station for five weeks; researchers will compare them with identical models kept on Earth to examine cellular-level effects. A space crops experiment compares Earth-grown and station-grown plants infected with a disease-causing fungus to test whether disease develops faster or more severely in microgravity.

The mission also carries the first test of a compact microplate reader delivered earlier this year, which is intended to measure biomarkers such as antibodies, antigens and proteins aboard the station rather than after samples return to Earth. A fourth investigation, making its fourth and final planned stay, has astronauts sample station surfaces to track how antibiotic-resistant bacteria survive and evolve in microgravity.